To examine the relation between the rli32-induced type I IFN response and intracellular growth of L. monocytogenes, we treated macrophages with ruxolitinib (1 μM and 10 μM), an inhibitor of IFN-signaling (42), using the infection conditions described for the experiment represented in Fig. 5A. The gene discussed is IFNA1; the disease is infection.